Alcántara OMÁ, Aguinaga RM, González del ÁA, Zavaleta AMJ, Acevedo GS, Mayén MDG, Castillo RV

Language: Spanish
References: 21
Page: 103-109
PDF size: 83.27 Kb.

ABSTRACT

Background: Duchenne muscular dystrophy (DMD) is the most frequent inherited and lethal neuromuscular disorder in humans. Molecular prenatal diagnosis of DMD through amniocentesis is a real preventive reproductive option in our country, although experience with chorionic villus sampling is still limited (CVS).
Objective: Perform the first prenatal diagnosis in an obligate DMD carrier woman in Mexico by CVS.
Material and method: CVS was performed in an obligate DMD carrier woman in which no partial intragenic deletions were present but a haplotype at-risk was identified. Cytogenetic analysis with GTG banding was performed and genomic DNA extraction from CVS sample was done without culture. Fetal gender assignment was achieved by ultrasonography at 12 weeks of gestation and confirmed by PCR amplification of two Y chromosome-linked loci (SRY and DYS389I/II). Identification of the DMD haplotype at-risk in the fetus was done through analysis of the intragenic markers pERT87.8/TaqI and pERT87.15/XmnI.
Results: Absence of PCR products corresponding to Y chromosome-linked loci in DNA CVS sample was compatible with a female fetus; it was confirmed later by cytogenetic study and prenatal ultrasound follow-up. Linkage analysis reveals that the female fetus inherited the DMD haplotype at-risk. We did not identify any maternal DNA contamination in CVS molecular analysis and these results were postnatally confirmed in DNA obtained from buccal cells.
Conclusion: Molecular prenatal diagnosis through chorionic villus sampling could be an early reproductive prevention strategy applicable to Duchenne/Becker muscular dystrophy carrier women in our country.

REFERENCES

1. Emery AE. The muscular dystrophies. Lancet 2002;359:687-95.

2. Mostacciuolo ML, Miorin M. Reapprasial of the incidence rate of Duchenne and Becker muscular dystrophies on the basis of molecular diagnosis. Neuroepidemiology 1993;12:326-30.

3. Abbs S, Yau SC, Mathew CG, Bobrow M. A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods. J Med Genet 1991;28:304-11.

4. Kim UK, Chae JJ, Lee SH, Lee CC, Namkoong Y. Molecular diagnosis of Duchenne/Becker muscular dystrophy by polymerase chain reaction and microsatellite analysis. Mol Cells 2002;13:385-8.

5. Roberts R, Cole C, Hart K, Bobrow M. Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy. Nucleic Acids Res 1989;17:811-7.

6. Abbs S. Prenatal diagnosis of Duchenne and Becker muscular dystrophy. Prenat Diagn 1996;16:1187-98.

7. Alcantara M, Garcia-Cavazos R, Hernández UE, Gonzalezdel Angel A, et al. Carrier detection and prenatal molecular diagnosis in a Duchenne muscular dystrophy family without any affected relative available. Ann Genet 2001;44:149-53.

8. Efrat Z, Perri T, Ramati E, Tugendreich D, Meizner I. Fetal gender assignment by fi rst-trimester ultrasound. Ultrasound Obstet Gynecol 2006;27:619-20.

9. Simoni G, Brambati B, Danesino C, Rossella F, et al. Effi cient direct chromosomal analysis and enzyme determination from chorionic villi samples in the fi rst trimester of pregnancy. Hum Genet 1983;63:349-57.

10. Jackson L. Prenatal genetic diagnosis by chorionic villus sampling (CVS). Sem Perinatol 1985;9:209-18.

11. Jordan BK, Jain M, Natarajan S, Douglas Fraiser S, Vilain E. Familial mutation in the testis-determining gene SRY shared by an XY female and her normal father. J Clin Endocrinol Metab 2002;87:3428-32.

12. Desnick RJ, Schuette JL, Golbus MS, Jackson L, et al. First-trimester biochemical and molecular diagnoses using chorionic villi: high accuracy in the U.S. collaborative study. Prenat Diagn 1992; 12:357-372.

13. Grether P, Zavaleta MJ, de la Luna E, Sanchez-Solis V, et al. Diagnóstico perinatal en 350 amnocentesis. Ginecol Obstet Mex 1991;59:317-22.

14. Eiben B, Trawicki W, Hammans W, Goebel R, et al. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fl uorescence in situ hybridization. Evaluation of 3,000 cases. Fetal Diagn Ther 1999;14:193-7.

15. Hussey ND, Donggui H, Froiland DAH, et al. Analysis of fi ve Duchenne muscular dystrophy exons and gender determination using conventional duplex polymerase chain reaction on single cells. Mol Hum Reprod 1999;5:1089-94.

16. Antoniadi T, Yapijakis C, Kaminopetros P, Makatsoris C, et al. A simple and effective approach for detecting maternal cell contamination in molecular prenatal diagnosis. Prenat Diagn 2002;22:425-9.

17. Wang BT, Peng W, Cheng KT, Chiu SF, et al. Chorionic villi sampling: laboratory experience with 4,000 consecutive cases. Am J Med Genet 1994;53:307-16.

18. Borry P, Fryns JP, Schotsmans P, Dierickx K. Attitudes towards carrier testing in minors: a systematic review. Genet Couns 2005; 16:341-52.

19. American Society of Human Genetics, American College of Medical Genetics (ASHG/ACMG). Points to consider: ethical legal, and psychosocial implications of genetic testing in childhood and adolescents. Am J Hum Genet 1995;57:1233-41.

20. Borry P, Schotsmans P, Fryns JP, Dierickx K. Carrier testing in minors: a systematic review of guidelines and positions statements. Eur J Hum Genet 2006;14:133-8.

21. Politano L, Nigro V, Nigro G, Petretta VR, et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996;275:1335-8.